N-acetylcysteine (NAC) inhibits cell growth by mediating the EGFR/Akt/HMG box-containing protein 1 (HBP1) signaling pathway in invasive oral cancer

Oral Oncology

Volumn 49, Issue 2, 2013, Pages 129-135

  Lee, Ming Fen ^a   Chan, Chien Yi ^b   Hung, Hsiao Chi ^b   Chou, I Tai ^b   Yee, Amy S ^c   Huang, Chun Yin ^b  

^a CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor receptor; HMG box containing protein 1; N acetylcysteine; Oral cancer

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETYLCYSTEINE; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; HMG BOX CONTAINING PROTEIN 1; PROTEIN KINASE B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CANCER PROGNOSIS; CELL CYCLE ARREST; COLONY FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TONGUE CARCINOMA; TUMOR XENOGRAFT;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL DIVISION; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HIGH MOBILITY GROUP PROTEINS; HUMANS; MALE; MICE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84872310988     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.08.003     Document Type: Article

References (38)

1. O. Demirkol, C. Adams, and N. Ercal Biologically important thiols in various vegetables and fruits J Agric Food Chem 52 2004 8151 8154
2. G.A. Souza, G.X. Ebaid, F.R. Seiva, K.H. Rocha, C.M. Galhardi, and F. Mani N-acetylcysteine an allium plant compound improves high-sucrose diet-induced obesity and related effects Evid Based Complement Alternat Med 2008
3. P.J. Millea N-acetylcysteine: multiple clinical applications Am Fam Physician 80 2009 265 269
4. G.S. Kelly Clinical applications of N-acetylcysteine Altern Med Rev 3 1998 114 127
5. S. De Flora, A. Izzotti, F. D'Agostini, and R.M. Balansky Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points Carcinogenesis 22 2001 999 1013
6. M. Zahid, M. Saeed, M.F. Ali, E.G. Rogan, and E.L. Cavalieri N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells Free Radic Biol Med 49 2010 392 400
7. S. Oka, H. Kamata, K. Kamata, H. Yagisawa, and H. Hirata N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases FEBS Lett 472 2000 196 202
8. A. Albini, M. Morini, F. D'Agostini, N. Ferrari, F. Campelli, and G. Arena Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine Cancer Res 61 2001 8171 8178
9. S. Kawakami, Y. Kageyama, Y. Fujii, K. Kihara, and H. Oshima Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells Anticancer Res 21 2001 213 219
10. J. Yang, Y. Su, and A. Richmond Antioxidants tiron and N-acetyl-l-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway Free Radic Biol Med 42 2007 1369 1380
11. H. Kamata, Y. Shibukawa, S.I. Oka, and H. Hirata Epidermal growth factor receptor is modulated by redox through multiple mechanisms. Effects of reductants and H2O2 Eur J Biochem 267 2000 1933 1944
12. J.J. Sheu, C.H. Hua, L. Wan, Y.J. Lin, M.T. Lai, and H.C. Tseng Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma Cancer Res 69 2009 2568 2576
13. C.H. Chung, K. Ely, L. McGavran, M. Varella-Garcia, J. Parker, and N. Parker Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol 24 2006 4170 4176
14. S. Temam, H. Kawaguchi, A.K. El-Naggar, J. Jelinek, H. Tang, and D.D. Liu Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer J Clin Oncol 25 2007 2164 2170
15. H. Modjtahedi, and S. Essapen Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities Anticancer Drugs 20 2009 851 855
16. B. Burtness The role of cetuximab in the treatment of squamous cell cancer of the head and neck Expert Opin Biol Ther 5 2005 1085 1093
17. B. Burtness, M.A. Goldwasser, W. Flood, B. Mattar, and A.A. Forastiere Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study J Clin Oncol 23 2005 8646 8654
18. M.C. Dobelbower, S.M. Russo, K.P. Raisch, L.L. Seay, L.K. Clemons, and S. Suter Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study Anticancer Drugs 17 2006 95 102
19. V. Ratushny, I. Astsaturov, B.A. Burtness, E.A. Golemis, and J.S. Silverman Targeting EGFR resistance networks in head and neck cancer Cell Signal 21 2009 1255 1268
20. A.S. Yee, E.K. Paulson, M.A. McDevitt, K. Rieger-Christ, I. Summerhayes, and S.P. Berasi The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression Gene 336 2004 1 13
21. S.G. Tevosian, H.H. Shih, K.G. Mendelson, K.A. Sheppard, K.E. Paulson, and A.S. Yee HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family Genes Dev 11 1997 383 396
22. H.H. Shih, S.G. Tevosian, and A.S. Yee Regulation of differentiation by HBP1, a target of the retinoblastoma protein Mol Cell Biol 18 1998 4732 4743
23. S.P. Berasi, M. Xiu, A.S. Yee, and K.E. Paulson HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase Mol Cell Biol 24 2004 3011 3024
24. Y.C. Chen, X.W. Zhang, X.H. Niu, D.Q. Xin, W.P. Zhao, and Y.Q. Na Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer Oncogene 29 2010 3067 3078
25. H.H. Shih, M. Xiu, S.P. Berasi, E.M. Sampson, A. Leiter, and K.E. Paulson HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue Mol Cell Biol 21 2001 5723 5732
26. K.M. Lin, W.G. Zhao, J. Bhatnagar, W.D. Zhao, J.P. Lu, and S. Simko Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity Leukemia 15 2001 601 612
27. K.E. Paulson, K. Rieger-Christ, M.A. McDevitt, C. Kuperwasser, J. Kim, and V.E. Unanue Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer Cancer Res 67 2007 6136 6145
28. C.J. Yao, K. Works, P.A. Romagnoli, and G.E. Austin Effects of overexpression of HBP1 upon growth and differentiation of leukemic myeloid cells Leukemia 19 2005 1958 1968
29. J. Kim, X. Zhang, K.M. Rieger-Christ, I.C. Summerhayes, D.E. Wazer, and K.E. Paulson Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1 J Biol Chem 281 2006 10865 10875
30. Y. Ohnishi, O. Lieger, M. Attygalla, T. Iizuka, and K. Kakudo Effects of epidermal growth factor on the invasion activity of the oral cancer cell lines HSC3 and SAS Oral Oncol 44 2008 1155 1159
31. S. Donnini, M. Monti, C. Castagnini, R. Solito, M. Botta, and S. Schenone Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling Int J Cancer 120 2007 995 1004
32. K. Saito, K. Uzawa, A. Kasamatsu, K. Shinozuka, K. Sakuma, and M. Yamatoji Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells Br J Cancer 101 2009 684 690
33. Y. Al-Tonbary, M. Al-Haggar, R. El-Ashry, S. El-Dakroory, H. Azzam, and A. Fouda Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia Adv Hematol 2009 2009 689639
34. M. Liu, J.C. Pelling, J. Ju, E. Chu, and D.E. Brash Antioxidant action via p53-mediated apoptosis Cancer Res 58 1998 1723 1729
35. J.W. Chiao, F. Chung, J. Krzeminski, S. Amin, R. Arshad, and T. Ahmed Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate Int J Oncol 16 2000 1215 1219
36. P.A. Havre, S. O'Reilly, J.J. McCormick, and D.E. Brash Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine Cancer Res 62 2002 1443 1449
37. A.C. Gustafsson, I. Kupershmidt, E. Edlundh-Rose, G. Greco, A. Serafino, and E.K. Krasnowska Global gene expression analysis in time series following N-acetyl l-cysteine induced epithelial differentiation of human normal and cancer cells in vitro BMC Cancer 5 2005 75
38. K. Kozaki, I. Imoto, A. Pimkhaokham, S. Hasegawa, H. Tsuda, and K. Omura PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma Cancer Sci 97 2006 1351 1358